Analgesic effect of Gabapentin after septal deviation surgeury

Evaluation of effectiveness of Gabapentin in lowering pain and Pethidine consumption in patients undergoing septal deviation surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012080510509N1

Enrollment

Registered

2012-10-17

Start date

2009-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Acute Pain

Interventions

Intervention 1: Treatment group received 800 milligram Gabapentin one hour before surgery. Intervention 2: Control group received placebo one hour before surgery.

Treatment - Drugs

Treatment group received 800 milligram Gabapentin one hour before surgery

Control group received placebo one hour before surgery

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : ASAclass I ; min age18 ; max age 40 ; min weight 40kg; Exclusion criteria : allergy to Gabapentin ; epilepsy ; and previous treatment with Gabapentin ; a chronic pain syndrome ; a history of cardiovascular ; respiratory ; renal or hepatic disease ; psychiatric disorders ; substance abuse

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1,4,8,12,16,20,24 hour after surgery. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Pethidine Consumption. Timepoint: 24 hour after surgery. Method of measurement: Milligram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sholeh Nesioonpour

School of Medicine , JundiShapur University of Medical Sciences

nesioonpour-sh@ajums.ac.ir+98 61 1222 0168

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026